InnovAge (INNV) Stock Price, News & Analysis

Company Overview

InnovAge (NASDAQ: INNV) is a healthcare company that provides comprehensive care and support services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). Its model is designed to help eligible seniors remain living in their homes and communities while receiving coordinated medical, behavioral, rehabilitation and social services.

The company operates PACE centers that combine primary and specialty medical care, nursing, therapy, pharmacy services, transportation, meals and social activities. InnovAge also provides in-home care and other supportive services, coordinating care through interdisciplinary teams that assess and manage each participant’s health and daily living needs.

InnovAge traces its origins to Total Longterm Care, a nonprofit PACE organization established in Colorado in the 1990s, and later expanded its operations under the InnovAge name. The company serves communities primarily in Colorado and California through a network of PACE centers and related services. Its programs generally serve older adults who meet applicable age, health and eligibility requirements for PACE participation.

Key Stats

• Today's Range: $8.74 to $9.08
• 50-Day Range: $8.80 to $11.81
• 52-Week Range: $3.93 to $12.64
• Volume: 1.18 million shs
• Average Volume: 802,034 shs
• Market Capitalization: $1.22 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.50
• Consensus Rating: Reduce

InnovAge Stock Analysis - MarketRank™

InnovAge scored higher than 51% of companies evaluated by MarketBeat, and ranked 490th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.7 / 5
• Analyst Rating: Reduce

Consensus Rating

InnovAge has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 2 sell ratings.

Upside Potential

InnovAge has a consensus price target of $10.50, representing about 17.2% upside from its current price of $8.96.

Amount of Analyst Coverage

InnovAge has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 11.63%

Earnings Growth

Earnings for InnovAge are expected to grow by 11.63% in the coming year, from $0.43 to $0.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InnovAge is -448.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of InnovAge is -448.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

InnovAge has a P/B Ratio of 5.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.87% of the float of InnovAge has been sold short.

Short Interest Ratio / Days to Cover

InnovAge has a short interest ratio ("days to cover") of 3.81, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in InnovAge has recently increased by 14.30%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InnovAge does not currently pay a dividend.

Dividend Growth

InnovAge does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.58

News Sentiment

InnovAge has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for InnovAge this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for INNV on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

1 people have added InnovAge to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $92,707,182.00 in company stock.

Percentage Held by Insiders

1.00% of the stock of InnovAge is held by insiders.

Percentage Held by Institutions

12.26% of the stock of InnovAge is held by institutions.

Company Calendar

• Last Earnings: 9/08/2026
• Today: 10/04/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:INNV
• Previous Symbol: OTCMKTS:INNV
• CIK: 1834376
• Web: www.innovage.com
• Phone: 844-803-8745
• Fax: N/A
• Employees: 2,500
• Year Founded: 1990

Price Target and Rating

• Average Price Target for InnovAge: $10.50
• High Price Target: $14.00
• Low Price Target: $7.00
• Potential Upside/Downside: +17.2%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.84
• P/E Growth: N/A
• Net Income: -$2.54 million
• Net Margins: -0.26%
• Pretax Margin: 0.03%
• Return on Equity: -1.03%
• Return on Assets: -0.47%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $989.71 million
• Price / Sales: 1.24
• Cash Flow: $0.14 per share
• Price / Cash Flow: 62.77
• Book Value: $1.76 per share
• Price / Book: 5.09

Miscellaneous

• Outstanding Shares: 136,450,000
• Free Float: 135,086,000
• Market Cap: $1.22 billion
• Optionable: Optionable
• Beta: 0.15